Wilmer Cutler Pickering Hale and Dorr advised MicroStrategy Incorporated in the offering, and Davis Polk & Wardwell advised the representative of the several initial purchasers. MicroStrategy...
MicroStrategy Incorporated’s $1.01 Billion Convertible Senior Notes Offering
Medtronic’s €3.0 Billion Senior Notes Offering
Wilmer Cutler Pickering Hale and Dorr represented Medtronic, Inc. in the offering. Medtronic plc (NYSE: MDT) announced it closed its €3 billion public offering, consisting of...
MicroStrategy’s $800 Million Convertible Senior Notes Offering
Wilmer Cutler Pickering Hale and Dorr represented MicroStrategy® Incorporated in the offering, and Davis Polk & Wardwell advised the representative of the initial purchasers. MicroStrategy Incorporated...
Arvinas’ $350 Million Private Placement
Wilmer Cutler Pickering Hale and Dorr advised Arvinas, Inc. on the transaction. Arvinas, Inc. (Nasdaq: ARVN) (“Arvinas”) announced that it entered into a securities purchase agreement with a...
CinCor Pharma’s $193.6 Million IPO
Wilmer Cutler Pickering Hale and Dorr advised the underwriters on the deal. CinCor Pharma, Inc. (“CinCor”) (Nasdaq: CINC), a clinical-stage biopharmaceutical company focused on developing its...
Amylyx Pharmaceuticals’ $190 Million IPO
Wilmer Cutler Pickering Hale and Dorr advised the underwriters on the deal while Goodwin Procter represented Amylyx Pharmaceuticals. Amylyx Pharmaceuticals, Inc. (“Amylyx”), a clinical-stage pharmaceutical company...
Viridian Therapeutics’ $97.7 Million Shares Offering
Wilmer Cutler Pickering Hale and Dorr advised the underwriters on the deal. Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical company advancing new treatments for patients suffering...
Icosavax’s $209.3 Million IPO
Latham & Watkins represented Icosavax, while Wilmer Cutler Pickering Hale and Dorr advised the underwriters on the deal. Icosavax, Inc. (Nasdaq: ICVX), a biopharmaceutical company leveraging its...
Symphony’s Acquisition of Cloud9 Technologies
Goodwin Procter LLP advised Symphony on the deal while Wilmer Cutler Pickering Hale and Dorr represented Cloud9 Technologies. Symphony announced its acquisition of Cloud9 Technologies. Symphony is...
Cue Health Inc.’s $235 Million Private Financing Round
Wilmer Cutler Pickering Hale and Dorr advised Cue Health Inc. on the deal. Cue Health Inc., a health technology company, announced the closing of its $235...
Ikena Oncology’s $143.8 Million IPO
Wilmer Cutler Pickering Hale and Dorr advised the underwriters on the deal. Ikena Oncology, Inc. (Nasdaq: IKNA) (“Ikena”), a targeted oncology company focused on developing cancer...